Inventor · disambiguated record
Krista Kinneer
Also filed as: KINNEER KRISTA · KINNEER KRISTA LYNNE
7 granted patents·5 pending applications·27 citations·filing 2012–2024
80Inventor score
Top patents by PatentIndex Score
12 records- 0192US10988546B2BCMA monoclonal antibody-drug conjugateMEDIMMUNE LLC·Filed 2018·Granted Apr 27, 2021·8 cites·14 claims
- 0287US9220775B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Dec 29, 2015·15 cites·39 claims
- 0381US11795225B2Therapeutic binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Oct 24, 2023·1 cites·38 claims
- 0479US10040857B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2015·Granted Aug 7, 2018·3 cites·56 claims
- 0576US2024294666A1BCMA Monoclonal Antibody-Drug ConjugateMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0670US2024239894A1Therapeutic binding moleculesMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 0769US11912782B2BCMA monoclonal antibody-drug conjugateMEDIMMUNE LLC·Filed 2021·Granted Feb 27, 2024·0 cites·19 claims
- 0865US11091554B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2018·Granted Aug 17, 2021·0 cites·20 claims
- 0962US2024075160A1Combination therapies for treatment of cancerMEDIMMUNE LLC·Filed 2023·Application pending·0 cites
- 1052US11305012B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2014·Granted Apr 19, 2022·0 cites·14 claims
- 1150US2023310636A1Combination therapies for treatment of cancer with therapeutic binding moleculesMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 1247US2022218835A1Combination therapyMEDIMMUNE LLC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →